Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 5
2008 1
2009 2
2010 1
2011 2
2012 5
2013 3
2014 2
2015 2
2016 3
2017 5
2018 6
2019 4
2020 6
2021 8
2022 6
2023 5
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Putative mechanism for anticancer properties of Ag-PP (NPs) extract.
Homayouni-Tabrizi M, Soltani M, Karimi E, Namvar F, Pouresmaeil V, Es-Haghi A. Homayouni-Tabrizi M, et al. Among authors: es haghi a. IET Nanobiotechnol. 2019 Aug;13(6):617-620. doi: 10.1049/iet-nbt.2018.5199. IET Nanobiotechnol. 2019. PMID: 31432795 Free PMC article.
Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models.
Banihashemi SR, Es-Haghi A, Fallah Mehrabadi MH, Nofeli M, Mokarram AR, Ranjbar A, Salman M, Hajimoradi M, Razaz SH, Taghdiri M, Bagheri M, Dadar M, Hassan ZM, Eslampanah M, Salehi Najafabadi Z, Lotfi M, Khorasani A, Rahmani F. Banihashemi SR, et al. Among authors: es haghi a. Front Immunol. 2022 May 26;13:836745. doi: 10.3389/fimmu.2022.836745. eCollection 2022. Front Immunol. 2022. PMID: 35693788 Free PMC article.
Phase II, Safety and Immunogenicity of RAZI Cov Pars (RCP) SARS Cov-2 Vaccine in Adults Aged 18-70 Years; A Randomized, Double-Blind Clinical Trial.
Mohazzab A, Fallah Mehrabadi MH, Es-Haghi A, Kalantari S, Mokhberalsafa L, Setarehdan SA, Sadeghi F, Rezaei Mokarram A, Haji Moradi M, Razaz SH, Taghdiri M, Ansarifar A, Lotfi M, Khorasani A, Nofeli M, Masoumi S, Boluki Z, Erfanpoor S, Bagheri Amiri F, Esmailzadehha N, Filsoof S, Mohseni V, Ghahremanzadeh N, Safari S, Shahsavan M, Bayazidi S, Raghami Derakhshani M, Rabiee MH, Golmoradi-Zadeh R, Khodadoost B, Solaymani-Dodaran M, Banihashemi SR. Mohazzab A, et al. Among authors: es haghi a. J Pharm Sci. 2023 Dec;112(12):3012-3021. doi: 10.1016/j.xphs.2023.09.027. Epub 2023 Oct 11. J Pharm Sci. 2023. PMID: 37832918 Clinical Trial.
67 results